202 related articles for article (PubMed ID: 1692930)
41. Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate.
McGuire JJ; Anderson DJ; McDonald BJ; Narayanasami R; Bennett BM
Biochem Pharmacol; 1998 Oct; 56(7):881-93. PubMed ID: 9774150
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of the pharmacological actions of glyceryl trinitrate after the electroporetic delivery of a glutathione S-transferase inhibitor.
Simon WC; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 1996 Dec; 279(3):1535-40. PubMed ID: 8968380
[TBL] [Abstract][Full Text] [Related]
43. Identification of the enzymatic mechanism of nitroglycerin bioactivation.
Chen Z; Zhang J; Stamler JS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8306-11. PubMed ID: 12048254
[TBL] [Abstract][Full Text] [Related]
44. Impaired nitroglycerin biotransformation in patients with chronic heart failure.
Petersson M; Rundqvist B; Bennett BM; Adams MA; Friberg P
Clin Physiol Funct Imaging; 2008 Jul; 28(4):229-34. PubMed ID: 18384624
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of the action of nitric oxide prodrugs by pyocyanin: mechanistic studies.
Hussain AS; Bozinovski J; Maurice DH; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 May; 75(5):398-406. PubMed ID: 9250373
[TBL] [Abstract][Full Text] [Related]
46. Thiol agents potentiate glyceryl trinitrate mediated relaxation of rabbit taenia coli: evidence for thiol-dependent biotransformation.
Hussain AS; Abu-Zahra TN; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1997 Jul; 75(7):807-11. PubMed ID: 9315347
[TBL] [Abstract][Full Text] [Related]
47. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
[TBL] [Abstract][Full Text] [Related]
48. Effect of dexamethasone treatment on the biotransformation of glyceryl trinitrate: cytochrome P450 3A1 mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate.
McDonald BJ; Monkewich GJ; Long PG; Anderson DJ; Thomas PE; Bennett BM
Can J Physiol Pharmacol; 1994 Dec; 72(12):1513-20. PubMed ID: 7736342
[TBL] [Abstract][Full Text] [Related]
49. Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patch.
Santoro A; Rovati LC; Setnikar I; Caplain H; Gualano V
Arzneimittelforschung; 2000 Sep; 50(9):779-85. PubMed ID: 11050693
[TBL] [Abstract][Full Text] [Related]
50. Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea-pig and rabbit.
Kawada T; Ishibashi T; Sasage H; Kato K; Imai S
Gen Pharmacol; 1994 Nov; 25(7):1361-71. PubMed ID: 7896047
[TBL] [Abstract][Full Text] [Related]
51. Role of cyclic GMP of canine vascular smooth muscle in relaxation by organic nitrates.
Shibata T; Ogawa K; Ito T; Hashimoto H; Nakagawa H; Satake T
Jpn Circ J; 1986 Nov; 50(11):1091-9. PubMed ID: 3029446
[TBL] [Abstract][Full Text] [Related]
52. [Comparative pharmacology of glycerol-1-nitrate and glyceryl trinitrate in various species].
Leitold M; Laufen H; Yeates RA
Arzneimittelforschung; 1986 May; 36(5):814-21. PubMed ID: 3089233
[TBL] [Abstract][Full Text] [Related]
53. Biphasic relaxant curves to glyceryl trinitrate in rat aortic rings. Evidence for two mechanisms of action.
Malta E
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):236-43. PubMed ID: 2566926
[TBL] [Abstract][Full Text] [Related]
54. Correlation between vascular smooth muscle relaxation and increase in cyclic GMP induced by some organic nitro esters.
Axelsson KL; Andersson RG; Wikberg JE
Acta Pharmacol Toxicol (Copenh); 1981 Oct; 49(4):270-6. PubMed ID: 6282045
[TBL] [Abstract][Full Text] [Related]
55. Relaxation of bovine mesenteric artery induced by glyceryl trinitrate is attenuated by pertussis toxin.
Ahlner J; Axelsson KL; Ekstram-Ljusegren M; Friedman RL; Grundström N; Karlsson JO; Andersson RG
Pharmacol Toxicol; 1988 Mar; 62(3):155-8. PubMed ID: 2836843
[TBL] [Abstract][Full Text] [Related]
56. Possible involvement of nitroglycerin converting step in nitroglycerin tolerance.
Hasegawa K; Taniguchi T; Takakura K; Goto Y; Muramatsu I
Life Sci; 1999; 64(24):2199-206. PubMed ID: 10374909
[TBL] [Abstract][Full Text] [Related]
57. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
Bennett BM; Kobus SM; Brien JF; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):629-35. PubMed ID: 3084763
[TBL] [Abstract][Full Text] [Related]
58. Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle.
Ishibashi T; Hamaguchi M; Kato K; Kawada T; Ohta H; Sasage H; Imai S
Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):553-61. PubMed ID: 8391657
[TBL] [Abstract][Full Text] [Related]
59. Role of PKC in the attenuation of the cGMP-mediated relaxation of skinned resistance artery smooth muscle seen in glyceryl-trinitrate-tolerant rabbit.
Nakano Y; Kusama N; Kajikuri J; Suzuki Y; Kanmura Y; Itoh T
Br J Pharmacol; 2004 Feb; 141(3):391-8. PubMed ID: 14718264
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
Lee FW; Salmonson T; Metzler CH; Benet LZ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
